Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Operating costs | 0.02 | 0.02 | 0.05 | 0.02 | 0.02 | 0.26 | 0.34 | 0.09 | 0.06 | 0.11 | 0.08 | 0.06 |
| EBITDA | -0.02 | -0.02 | -0.05 | -0.02 | -0.02 | -0.26 | -0.34 | -0.09 | -0.01 | -0.11 | -0.08 | -0.06 |
| EBITDA margin % | -20.00% | |||||||||||
| Depreciation & amortisation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Finance costs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.16 | 0.00 |
| Non-operating income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.52 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Pre-tax profit | -0.02 | -0.02 | -0.05 | -0.02 | -0.02 | -0.25 | 0.07 | -0.09 | -0.01 | -0.09 | -0.24 | -0.06 |
| Effective tax rate % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Profit after tax | -0.02 | -0.02 | -0.05 | -0.02 | -0.02 | -0.25 | 0.07 | -0.09 | -0.01 | -0.09 | -0.24 | -0.06 |
| Earnings per share (Rs) | -0.05 | -0.05 | -0.12 | -0.05 | -0.05 | -0.59 | 0.16 | -0.21 | -0.02 | -0.21 | -0.56 | -0.14 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 |
| Operating costs | 0.03 | 0.03 | 0.03 | 0.03 | 0.06 | 0.07 | 0.08 | 0.19 | 0.10 | 0.60 | 0.34 | 0.31 |
| EBITDA | -0.03 | -0.03 | -0.03 | -0.03 | -0.06 | -0.07 | -0.08 | -0.19 | -0.10 | -0.60 | -0.29 | -0.26 |
| EBITDA margin % | -580.00% | -520.00% | ||||||||||
| Depreciation & amortisation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Finance costs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.16 | 0.16 |
| Non-operating income | 0.00 | -0.01 | -0.02 | -0.02 | 0.01 | 0.01 | 0.00 | 0.02 | 0.00 | 0.53 | 0.02 | 0.02 |
| Pre-tax profit | -0.04 | -0.05 | -0.06 | -0.06 | -0.06 | -0.07 | -0.09 | -0.18 | -0.10 | -0.18 | -0.43 | -0.40 |
| Effective tax rate % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Profit after tax | -0.04 | -0.05 | -0.06 | -0.05 | -0.06 | -0.07 | -0.08 | -0.17 | -0.10 | -0.18 | -0.43 | -0.40 |
| Earnings per share (Rs) | -0.09 | -0.12 | -0.14 | -0.12 | -0.14 | -0.16 | -0.19 | -0.40 | -0.23 | -0.42 | -1.01 | -0.93 |
| Paid out as dividend % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Revenue CAGR | % | % | % | % | ||
| Profit CAGR | % | % | % | -38% | ||
| Share price CAGR | 6% | 39% | 32% | 47% | ||
| Average return on equity | % | % | % | % |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net block (property, plant) | 0.20 | 0.19 | 0.19 | 0.18 | 0.17 | 0.17 | 0.16 | 0.16 | 0.15 | 0.15 | 0.00 | 0.00 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current & other assets | 0.11 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.01 | 0.00 | 0.03 | 0.01 |
| Total assets | 0.31 | 0.28 | 0.28 | 0.27 | 0.26 | 0.26 | 0.25 | 0.24 | 0.16 | 0.15 | 0.03 | 0.01 |
| Share capital | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 |
| Reserves & surplus | -6.00 | -6.04 | -6.09 | -6.15 | -6.20 | -6.26 | -6.33 | -6.41 | -6.58 | -6.68 | -6.86 | -7.29 |
| Total debt | 2.00 | 1.99 | 2.03 | 2.04 | 2.05 | 2.07 | 2.21 | 0.05 | 0.00 | 2.43 | 2.37 | 2.81 |
| Other liabilities & provisions | 0.04 | 0.06 | 0.07 | 0.11 | 0.14 | 0.18 | 0.10 | 2.33 | 2.47 | 0.13 | 0.25 | 0.22 |
| Equity + liabilities | 0.31 | 0.28 | 0.28 | 0.27 | 0.26 | 0.26 | 0.25 | 0.24 | 0.16 | 0.15 | 0.03 | 0.01 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.21 | -0.16 | -0.06 | -0.47 | -0.27 |
| Investing cash flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.21 | 0.16 | 0.06 | 0.59 | 0.44 |
| Free cash flow (after capex) | -0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.21 | -0.16 | -0.06 | 0.18 | -0.27 |
| Financing cash flow | 0.03 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.11 | -0.16 |
| Net change in cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Cash conversion (OCF / EBITDA) % | 75% | -33% | 0% | 0% | 0% | 0% | 0% | 2,762% | 84% | 60% | 78% | 93% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on capital employed % | -7.84% | -8.16% | -13.95% | -16.22% | -21.43% | -60.00% | -60.87% | |||||
| Receivable days | 0.00 | |||||||||||
| Inventory days | 0.00 | |||||||||||
| Payable days | ||||||||||||
| Cash cycle (days) | 0.00 | |||||||||||
| Working capital days | -1,606.00 |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter group % | 28.36% | 28.36% | 28.36% | 28.36% | 28.36% | 28.36% | 32.27% | 32.27% | 32.27% | 32.27% | 32.27% | 32.27% |
| Domestic institutions % | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% |
| Retail & others % | 70.69% | 70.69% | 70.68% | 70.69% | 70.69% | 70.69% | 66.78% | 66.78% | 66.78% | 66.78% | 66.77% | 66.77% |
| Shareholder count | 1,505 | 1,498 | 1,504 | 1,503 | 1,497 | 1,494 | 1,490 | 1,490 | 1,482 | 1,482 | 1,481 | 1,482 |
Fundamentals
Market value₹ 2.29 Cr.
Last price₹ 5.37
Book value / share₹ -7.07
Return on capital%
Return on equity%
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)%
Profit CAGR (TTM)-38%
Standalone figures.
Valuation
Market capRs 2 Cr
Enterprise valueRs 5 Cr
Price to book-0.76x
Price to sales45.90x
EV / sales101.90x
Earnings yield-17.43%
P/B, 3-year average-0.51x
P/B, 5-year average-0.45x
Profitability
Operating margin (excl. other income)-580.00%
Operating margin (incl. other income)-540.00%
EBITDA margin-480.00%
Pre-tax margin-800.00%
Net profit margin-800.00%
ROE15.33%
ROA-2150.00%
ROE, 3-year average8.92%
ROA, 3-year average-804.84%
ROE, 5-year average7.64%
ROA, 5-year average-506.43%
Other income / net worth-0.66%
Per share
EPS (TTM)Rs -0.94
EPS (latest year)Rs -1.01
EPS (latest quarter)Rs -0.14
EPS, 3-year averageRs -0.55
EPS, 5-year averageRs -0.45
Book value per shareRs -7.07
Sales per shareRs 0.12
Cash flow per shareRs -0.63
Efficiency
Asset turnover5.00x
Leverage
Total debtRs 3 Cr
Cash and bankRs 0 Cr
Net debtRs 3 Cr
Debt to equity-0.93x
Interest coverage-1.50x
Owners' fund to total sources-30200.00%
Debt to assets28100.00%
Cash flow
Operating cash flow (latest year)Rs -0 Cr
Investing cash flow (latest year)Rs 0 Cr
Financing cash flow (latest year)Rs -0 Cr
Net change in cash (latest year)Rs 0 Cr
Statement figures
Net sales (TTM)Rs 0 Cr
Net sales (latest year)Rs 0 Cr
Operating profit excl. other income (latest year)Rs -0 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs -0 Cr
Net profit (latest quarter)Rs -0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 4 Cr
ReservesRs -7 Cr
Shareholders' fundsRs -3 Cr
Total assetsRs 0 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)0.43
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | 531207 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +10.0% | -2.8% | +12.8 pts |
| 3 years | +128.5% | +14.2% | +114.3 pts |
| 5 years | +442.4% | +27.9% | +414.5 pts |
Red flags
F-score 2 of 6| serious | Negative equity Shareholders' equity is negative |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹0 Cr.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Cresanto Global Limited?
Cresanto Global Limited (531207) has a market capitalisation of Rs 2.29 Cr. at the 2026-09-15 close.
What were Cresanto Global Limited's latest quarterly results?
In the Jun 2026 quarter, Cresanto Global Limited sales was Rs 0 Cr with a net loss of Rs 0 Cr.